Kosior Dariusz, Chwyczko Tomasz, Stawicki Sławomir, Tadeusiak Wiesław, Rabczenko Daniel, Opolski Grzegorz
I Katedra i Klinika Kardiologii AM w Warszawie.
Pol Arch Med Wewn. 2003 Aug;110(2):827-36.
We performed direct comparison of safety and efficacy of monophasic and biphasic shock cardioversion (CV) of atrial fibrillation (AF). Troponin I (cTnl) and myoglobin (My) were used as markers of potential myocardial and skeletal muscle damage during the procedure.
63 patients (p.t.s.) with persistent, nonvalvular AF (F/M 18/45; mean age 61.6 +/- 11.4 years) were randomized to CV either with monophasic (F/M 10/24, Group I) or biphasic (F/M 8/21, Group II) shock. Plasma levels of cTnl and My were measured before CV, 6 hours and 24 hours after CV.
The efficacy of CV was significantly higher in Group II (93% vs 85%, p < 0.04). Sinus rhythm restoration required lower total energy used during procedure with biphasic shock (379.8 +/- 301.5 vs 192.8 +/- 100.6 J; p 0.001). There was no significant difference in mean values of cTnl before CV in both groups (0.3 +/- 0.2 vs 0.2 +/- 0.1 ng/mL, p > 0.15). In 14 pts (41%) from Group I and 3 pts (10%) from Group II plasma cTnl concentration above discriminatory level (0.9 ng/mL) were noted. There was a significant increase in mean plasma cTnl level (0.3 +/- 0.2 vs 1.9 +/- 0.9 ng/mL, p < 0.04) 24 hours after the procedure in Group I. We did not observed significant differences in cTnl plasma concentration 6 and 24 hours after CV in Group II (0.2 +/- 0.1 vs 0.4 +/- 0.2 ng/mL, p > 0.15). Both study groups did not significantly differ in mean serum My level at baseline (39.1 +/- 14.2 vs 43.1 +/- 20.9 ng/mL). In Group I mean My serum concentration increased during the first 6 hours after CV (43.1 +/- 20.9 vs 247.9 +/- 53.3 ng/mL, p < 0.02) and there was a significant decreasing in My serum level during the further observation (247.9 +/- 53.3 vs 104.5 +/- 46.1 ng/mL, p < 0.03). Mean serum My concentration remained within normal ranges during the 24 hour follow-up after the biphasic shock CV (43.1 +/- 20.9 vs 43.6 +/- 29.1 ng/mL). Increased of cTnl and My in Group I may be due to myocardial and skeletal muscle damage and correlate closely with cumulative energy delivered (Spearmann correlation index (r) = 0.55, p < 0.01 for My and r = 0.66, p < 0.01 for cTnl). In Group I positive correlation between cumulative energy used during CV and increase of studied markers indexed with left ventricular mass (r = 0.6, p < 0.05 for My and r = 0.74, p < 0.04 for cTnl) was observed. There was no significant correlation between delivered energy and increase of heart markers in Group II noted.
We observed the significant increase in mean serum cTnl and My level 24 hours after CV with monophasic shock and its positive correlation with total energy used during the procedure. There is a conclusion that biphasic shock used during CV of AF is more efficient and may cause less myocardial and skeletal muscle damage due to lower energy delivered.
我们对心房颤动(AF)的单相和双相电击复律(CV)的安全性和有效性进行了直接比较。肌钙蛋白I(cTnl)和肌红蛋白(My)被用作该过程中潜在心肌和骨骼肌损伤的标志物。
63例持续性、非瓣膜性AF患者(F/M 18/45;平均年龄61.6±11.4岁)被随机分为接受单相电击复律(F/M 10/24,I组)或双相电击复律(F/M 8/21,II组)。在CV前、CV后6小时和24小时测量血浆cTnl和My水平。
II组的CV有效性显著更高(93%对85%,p<0.04)。双相电击复律过程中恢复窦性心律所需的总能量更低(379.8±301.5对192.8±100.6 J;p 0.001)。两组CV前cTnl的平均值无显著差异(0.3±0.2对0.2±0.1 ng/mL,p>0.15)。I组14例患者(41%)和II组3例患者(10%)的血浆cTnl浓度高于鉴别水平(0.9 ng/mL)。I组在术后24小时血浆cTnl平均水平显著升高(0.3±0.2对1.9±0.9 ng/mL,p<0.04)。II组在CV后6小时和24小时的cTnl血浆浓度无显著差异(0.2±0.1对0.4±0.2 ng/mL,p>0.15)。两个研究组在基线时的平均血清My水平无显著差异(39.1±14.2对43.1±20.9 ng/mL)。I组在CV后的前6小时血清My浓度升高(43.1±20.9对247.9±53.3 ng/mL,p<0.02),在进一步观察期间血清My水平显著下降(247.9±53.3对104.5±46.1 ng/mL,p<0.03)。双相电击复律CV后的24小时随访期间,平均血清My浓度保持在正常范围内(43.1±20.9对43.6±29.1 ng/mL)。I组中cTnl和My的升高可能是由于心肌和骨骼肌损伤,并且与传递的累积能量密切相关(Spearmann相关指数(r)=0.55,My的p<0.01,cTnl的r=0.66,p<0.01)。在I组中观察到CV期间使用的累积能量与以左心室质量为指标的研究标志物增加之间存在正相关(My的r=0.6,p<0.05,cTnl的r=0.74,p<0.04)。II组中未观察到传递能量与心脏标志物增加之间的显著相关性。
我们观察到单相电击复律后24小时平均血清cTnl和My水平显著升高,并且与该过程中使用的总能量呈正相关。得出的结论是,AF的CV过程中使用的双相电击更有效,并且由于传递的能量较低,可能导致较少的心肌和骨骼肌损伤。